Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Rubius Therapeutics, Inc. RUBY
$0.02
-$0 (-9.00%)
На 18:01, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
1818708.00000000
-
week52high
1.57
-
week52low
0.01
-
Revenue
0
-
P/E TTM
0
-
Beta
2.37351300
-
EPS
-1.81000000
-
Last Dividend
0.00000000
-
Next Earnings Date
08 мая 2023 г. в 12:30
Описание компании
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatment of HPV-positive tumors; and RTX-T1D for treating type 1 diabetes. The company was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.
Рекомендации
аналитиков
Рекомендации аналитиков
Grading company | New grade | Previous grade | Recommendation date |
---|---|---|---|
SVB Leerink | Market Perform | Market Perform | 09 авг 2022 г. |
Morgan Stanley | Equal-Weight | Equal-Weight | 11 мая 2022 г. |
HC Wainwright & Co. | Buy | Buy | 11 мая 2022 г. |
SVB Leerink | Market Perform | Market Perform | 10 мая 2022 г. |
SVB Leerink | Market Perform | Market Perform | 11 апр 2022 г. |
Guggenheim | Neutral | Buy | 13 сент 2022 г. |
Morgan Stanley | Equal-Weight | Equal-Weight | 09 сент 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
---|---|---|---|---|
Appelhans Dannielle | D | 10385 | 3878 | 01 февр 2023 г. |
CAGNONI PABLO J | D | 66082 | 8448 | 01 февр 2023 г. |
Appelhans Dannielle | D | 22500 | 7500 | 31 янв 2023 г. |
Appelhans Dannielle | A | 14263 | 7500 | 31 янв 2023 г. |
Turka Laurence A. | D | 25875 | 8625 | 31 янв 2023 г. |
Turka Laurence A. | D | 18391 | 2593 | 31 янв 2023 г. |
Turka Laurence A. | A | 20984 | 8625 | 31 янв 2023 г. |
CAGNONI PABLO J | D | 75000 | 25000 | 31 янв 2023 г. |
CAGNONI PABLO J | D | 74530 | 7240 | 31 янв 2023 г. |
CAGNONI PABLO J | A | 81770 | 25000 | 31 янв 2023 г. |
Новостная лента
Why Is Rubius Therapeutics (RUBY) Stock Up 35% Today?
InvestorPlace
14 февр 2023 г. в 09:19
Rubius Therapeutics (NASDAQ: RUBY ) stock is heading higher on Tuesday despite a lack of news from the cellular medicines company. Instead, it looks like increasing interest from traders is behind today's gains as heavy trading takes place.
Why Is Rubius Therapeutics (RUBY) Stock Down 16% Today?
InvestorPlace
07 февр 2023 г. в 08:46
Rubius Therapeutics (NASDAQ: RUBY ) stock is falling hard on Tuesday after the biotechnology company received a Nasdaq delisting notice. According to a filing with the U.S. Securities and Exchange Commission (SEC), the company doesn't meet the requirements to list on The Nasdaq Stock Market.
Hot Penny Stocks to Buy This Week? 3 to Watch Now
PennyStocks
26 сент 2022 г. в 06:00
Which penny stocks are you watching today? The post Hot Penny Stocks to Buy This Week?
Rubius Therapeutics to Present at Guggenheim Nantucket Therapeutics Conference
GlobeNewsWire
19 сент 2022 г. в 08:00
CAMBRIDGE, Mass., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq: RUBY), a biopharmaceutical company that is developing an entirely new class of cellular medicines called Red Cell Therapeutics™ for the treatment of cancer and autoimmune diseases, today announced that Pablo J. Cagnoni, M.D., president and chief executive officer, will participate in a fireside chat at the Guggenheim Nantucket Therapeutics Conference on Thursday, September 29, 2022, at 11:15am EDT.
3 High Volume Penny Stocks To Watch Before Next Week
PennyStocks
09 сент 2022 г. в 06:00
Here's what you need to know about buying penny stocks on September 9th, 2022 The post 3 High Volume Penny Stocks To Watch Before Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.